CASSIN, RAMONA
CASSIN, RAMONA
Universita' degli Studi di MILANO
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
2023 A. Lombardi, G. Viero, S. Villa, S. Biscarini, E. Palomba, C. Azzara', N. Iannotti, B. Mariani, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, A. Grazia Valzano, L. Morlacchi, M. Francesca Donato, G. Castellano, R. Cassin, M. Carrabba, A. Muscatello, A. Gori, A. Bandera
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
2023 A. Lombardi, G. Viero, S. Villa, S. Biscarini, E. Palomba, C. Azzarà, N. Iannotti, B. Mariani, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, A. Grazia Valzano, L.C. Morlacchi, M. Francesca Donato, G. Castellano, R. Cassin, M. Carrabba, A. Muscatello, A. Gori, A. Bandera
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study
2022 S. Biscarini, S. Villa, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, N. Iannotti, M.M. Bolis, B. Mariani, A. Grazia Valzano, L.C. Morlacchi, F. Donato, G. Castellano, R. Cassin, M.D.R. Carrabba, A. Muscatello, A. Gori, A. Bandera, A. Lombardi
Assessment of the 4-factor score : Retrospective analysis of 586 CLL patients receiving ibrutinib : A campus CLL study
2021 F. Morabito, G. Tripepi, G. Del Poeta, F.R. Mauro, G. Reda, P. Sportoletti, L. Laurenti, M. Coscia, Y. Herishanu, M. Varettoni, R. Murru, A. Chiarenza, A. Visentin, A. Condoluci, R. Moia, D. Pietrasanta, G. Loseto, U. Consoli, I. Scortechini, F.M. Rossi, A. Zucchetto, E. Vigna, E.A. Martino, F. Mendicino, C. Botta, D. Caracciolo, R. Cassin, G. D'Arrigo, S. Galimberti, A. Rago, I. Angeletti, A. Biagi, I. Del Giudice, R. Bomben, A. Neri, G. Fronza, G. Cutrona, D. Rossi, F. Di Raimondo, A. Cuneo, G. Gaidano, A. Polliack, L. Trentin, R. Foa, M. Ferrarini, V. Gattei, M. Gentile
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine. Results of study on 486 cases outside clinical trials
2021 F. Morabito, G. Tripepi, G. Del Poeta, F.R. Mauro, G. Reda, P. Sportoletti, L. Laurenti, M. Coscia, Y. Herishanu, S. Bossio, M. Varettoni, R. Murru, A. Chiarenza, A. Visentin, A. Condoluci, R. Moia, D. Pietrasanta, G. Loseto, U. Consoli, I. Scortechini, F.M. Rossi, A. Zucchetto, H. Al-Janazreh, E. Vigna, E.A. Martino, R. Cassin, G. D'Arrigo, S. Galimberti, A. Rago, I. Angeletti, A. Biagi, I. Del Giudice, R. Bomben, A. Neri, G. Fronza, P. Monti, P. Menichini, J. Olivieri, G. Cutrona, D. Rossi, A. Cuneo, F. Di Raimondo, G. Gaidano, A. Polliack, L. Trentin, R. Foà, M. Ferrarini, V. Gattei, M. Gentile
Lymphocytic infiltrate and p53 protein expression as predictive markers of response and outcome in myelodysplastic syndromes treated with azacitidine
2021 C. Pescia, F. Boggio, G.A. Croci, R. Cassin, M. Barella, L. Pettine, G. Reda, E. Sabattini, C. Finelli, U. Gianelli
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases
2021 F. Morabito, G. Tripepi, G. Del Poeta, F.R. Mauro, G. Reda, P. Sportoletti, L. Laurenti, M. Coscia, Y. Herishanu, S. Bossio, M. Varettoni, R. Murru, A. Chiarenza, A. Visentin, A. Condoluci, R. Moia, D. Pietrasanta, G. Loseto, U. Consoli, I. Scortechini, F.M. Rossi, A. Zucchetto, H. Al-Janazreh, E. Vigna, E.A. Martino, F. Mendicino, R. Cassin, G. D'Arrigo, S. Galimberti, A. Rago, I. Angeletti, A. Biagi, I. Del Giudice, R. Bomben, A. Neri, G. Fronza, P. Monti, P. Menichini, G. Cutrona, O. Jaksic, D. Rossi, F. Di Raimondo, A. Cuneo, G. Gaidano, A. Polliack, L. Trentin, R. Foa, M. Ferrarini, V. Gattei, M. Gentile
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
2021 M. Jalink, S. Berentsen, J.J. Castillo, S.P. Treon, M. Cruijsen, B. Fattizzo, R. Cassin, D. Fotiou, E. Kastritis, M. De Haas, L.E.M. Oosten, H. Frederiksen, A. Patriarca, S. D'Sa, J.M.I. Vos
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 B. Fattizzo, J.A. Giannotta, W. Barcellini, M.C. Barbanti, C. Bucelli, R. Cassin, D. Cattaneo, F. Cavallaro, V. Ferla, N.S. Fracchiolla, A. Freyrie, G. Galassi, M.C. Goldaniga, F.I. Grifoni, A. Iurlo, G. Mangiameli, V. Mattiello, M. Meli, A. Neri, A. Noto, F. Onida, L. Ottani, R. Pasquale, L. Pettine, A. Pompa, G. Reda, F.G. Rossi, G.N. Saporiti, M. Sciumè, E. Tagliaferri, L. Baldini
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome : From Megakaryopoiesis to Immunomodulation
2019 B. Fattizzo, G. Levati, R. Cassin, W. Barcellini
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia
2019 G. Reda, R. Cassin, M. Gentile, F.R. Mauro, D. Giannarelli, B. Fattizzo, M. Barbieri, I. Silvestris, S. Fabris, F. Morabito, A. Neri, W. Barcellini, A. Cortelezzi
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL)
2019 R. Cassin, V. Mattiello, M. Viltadi, D. D'Aliberti, R. Piazza, C. Gambacorti-Passerini, U. Gianelli, A. Neri, A. Cortelezzi, G. Reda
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study
2018 G. Reda, B. Fattizzo, R. Cassin, V. Mattiello, T. Tonella, D. Giannarelli, F. Massari, A. Cortelezzi
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
2018 G. Reda, M. Riva, B. Fattizzo, R. Cassin, D. Giannarelli, M. Pennisi, A. Freyrie, R. Cairoli, A. Molteni, A. Cortelezzi
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia
2018 G. Reda, R. Cassin, A. Artoni, B. Fattizzo, A. Lecchi, S. La Marca, P. Bucciarelli, G.V. Levati, F. Peyvandi, A. Cortelezzi
Bone quality in beta-thalassemia intermedia : relationships with bone quantity and endocrine and hematologic variables
2017 M. Baldini, A. Marcon, F.M. Ulivieri, S. Seghezzi, R. Cassin, C. Messina, M.D. Cappellini, G. Graziadei
Biological and molecular characterization of a rare case of cutaneous Richter syndrome
2017 G. Reda, R. Cassin, S. Fabris, G. Ciceri, B. Fattizzo, M. Sciumè, N. Orofino, U. Gianelli, A. Neri, A. Cortelezzi
Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?
2017 G. Reda, R. Cassin, V. Mattiello, T. Tonella, D. Giannarelli, B. Fattizzo, F. Onida, F. Maria Massari, A. Cortelezzi
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report
2017 G. Reda, B. Fattizzo, R. Cassin, E. Flospergher, N. Orofino, U. Gianelli, W. Barcellini, A. Cortelezzi
Chronic lymphocytic leukemia and prognostic models : a bridge between clinical and biological markers
2017 G. Reda, R. Cassin, B. Fattizzo, D. Giannarelli, V. Mattiello, W. Barcellini, A. Cortelezzi